PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Musculoskeletal Disease, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.\', \'Department of Clinical Dermatology, IRCCS Galeazzi Orthopedic Institute, Milan, Italy.\', \'Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.\', \'Department of Medicine B, Sheba Medical Center, Tel Hashomer, Israel.\', \'Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel.\', \'Department of Health Sciences (DISSAL), School of Public Health, University of Genoa, Genoa, Italy.\', \'Laboratory for Industrial and Applied Mathematics (LIAM), Department of Mathematics and Statistics, York University, Toronto, Canada.\', \'Clinic of Rheumatology, ASUFC, Department of Medicine (DAME), University of Udine, Udine, Italy.\', \'Department of Clinical Immunology and Allergy, St James\'s University Hospital, Leeds, UK.\', \'National Institute for Health Research (NIHR), Leeds Biomedical Research Centre (BRC), Leeds Teaching Hospitals, Leeds, UK.\']
?:citedBy
  • -1
?:creator
?:hasPublicationType
?:journal
  • The Israel Medical Association journal : IMAJ
is ?:pmid of
?:pmid
?:pmid
  • 32558435
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Rationale for Evaluating PDE4 Inhibition for Mitigating against Severe Inflammation in COVID-19 Pneumonia and Beyond.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all